Vanguard Capital Management Acquires 5.08% Stake in Natera Inc (NTRA)

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, disclosing a new 5.08% stake in Natera Inc (NTRA). As of the event date on March 31, 2026, the investment adviser reported beneficial ownership of 7,205,939 shares of common stock. According to the filing, Vanguard holds sole dispositive power over all 7,205,939 shares, while maintaining sole voting power over 1,197,443 shares. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This position reflects the aggregate holdings of Vanguard Capital Management and several affiliates, including Vanguard Global Advisers, LLC and Vanguard Fiduciary Trust Company. The total value of the holding is estimated at approximately $1.49 billion based on the provided data. This filing marks a significant increase from a previous 0% ownership level, establishing Vanguard as a major institutional shareholder in the Austin-based genetic testing company.